insights_auto
Why is TCRX down 4.11%?
Dive Deeperchevron_right
TCRX:NASDAQ
Tscan Therapeutics Inc
$0.15
arrow_downward
-4.11%(-0.0066) 1D
Nov 16, 1:15:24 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TCRX...
Open
$0.16
High
$0.17
Low
$0.15
Mkt. cap
10.48M
Avg. vol.
549.53K
Volume
161.57K
52-wk high
$1.47
52-wk low
$0.15
EPS
-$0.89
Beta
1.21
Shares outstanding
63.50M
No. of employees
43
Open
$0.16
High
$0.17
Low
$0.15
Mkt. cap
10.48M
Avg. vol.
549.53K
Volume
161.57K
52-wk high
$1.47
52-wk low
$0.15
EPS
-$0.89
Beta
1.21
Shares outstanding
63.50M
No. of employees
43
News stories
From web sources and news partners
ChartMill
·
40 minutes ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
marketscreener.com
·
46 minutes ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
46 minutes ago
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Traders Union
·
2 hours ago
Peter Tuchman: S&P 500 loses over $800 billion in market cap
About Tscan Therapeutics Inc
CEO-
Employees43
Founded2018
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
IndustryBiotechnology
Websitetscan.com